Search

everythinglearnresearchcommunity

for

Search:↓

The compound 4c effectively inhibits the enzyme linked to hair loss.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Monocyclic aromatic compounds are important for developing various drugs and treatments.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

Indinavir therapy can cause reversible skin, hair, and nail darkening.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

5-ARI therapy may help prevent prostate cancer progression.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Farudodstat may effectively treat alopecia areata without harming hair follicles.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.